Skip to main content
. Author manuscript; available in PMC: 2013 Jul 24.
Published in final edited form as: JAMA. 2010 Sep 22;304(12):1358–1364. doi: 10.1001/jama.2010.1376

Table 2.

Multivariate Cox proportion hazard model for relapse, clonal evolution and survival

Relapse Clonal Evolution Survival

Risk factor HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
Telomere length 0.16 0.03, 0.69 0.01 0.29 0.11, 0.76 0.01 0.35 0.17, 0.73 0.005
Age (years) 1.03 1.01, 1.05 0.005 1.03 1.00, 1.05 0.01 1.03 1.02, 1.05 <0.001
ARC (/μL) 0.99 0.63, 1.55 0.96 1.10 0.55, 2.19 0.79 0.63 0.41, 0.97 0.03
ALC (/μL) 1.31 0.55, 3.10 0.54 1.16 0.51, 2.66 0.72 0.89 0.48, 1.66 0.72
ANC (/μL) 1.20 0.67, 2.16 0.54 0.70 0.38, 1.27 0.24 0.95 0.65, 1.38 0.78
Platelet (/μL) 0.80 0.46, 1.38 0.42 0.76 0.45, 1.28 0.30 1.11 0.73, 1.67 0.63

Continuous telomere length was used for relapse due to the linear relationship between relapse and telomere length. For clonal evolution and survival, short telomere was defined as an age-adjusted telomere length < first quartile and long telomere as an age-adjusted telomere length > first quartile. Natural log-transformed ARC, ALC, ANC and platelet count were used to reduce the skewness of these variables. ARC, absolute reticulocyte count, ALC, absolute lymphocyte count, ANC, absolute neutrophil count; HR; hazard ratio; 95% CI, 95% Confidence Interval.